Benign Malignant Nodules
Benign Malignant Nodules - Related Videos
05:24
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
0 Views •
Cited by 2 •
2025
This study introduces multifractal spectrum analysis for assessing pulmonary nodule malignancy. Using CT-DICOM data, the method calculates fractal dimensions across multiple voxel scales, revealing significant differences between early-stage and late-stage pulmonary nodules.
08:33
Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
0 Views •
Cited by 22 •
2014
Three dimensional culture of mammary epithelial cells on a reconstituted basement membrane is a useful method to recapitulate the in vivo architecture of the benign breast, and to differentiate the malignant phenotype from the benign breast phenotype. Importantly, this system can be applied to study invasive carcinomas in other tissues.
08:38
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
0 Views •
Cited by 13 •
2013
We describe the manufacture of compressed hormone pellets, as well as subcutaneous surgical implantation into mice. This strategy can be combined with the growth of cell and tissue xenografts under the renal capsule of athymic nude mice to evaluate hormonal carcinogenesis and regulation of benign prostate growth.
08:32
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
0 Views •
Cited by 9 •
2019
Transgenic lck:eGFP zebrafish express GFP highly in T lymphocytes, and have been used to study T cell development and acute lymphoblastic leukemia. This line can be used to study B cells, which express lck at lower levels. This protocol describes purification of malignant and non-malignant B cells from lck:eGFP zebrafish.
07:23
A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
0 Views •
Cited by 5 •
2013
Cooperation between an activated oncogene like RASV12 and mutations in cell polarity genes like scribbled, result in tumor growth in Drosophila where tumor cells also display invasive behaviors. Here a simple protocol for the induction and observation of the benign and invasive tumors is presented.
FAQs
These features provide complementary clues about how a nodule should be evaluated clinically. Size helps establish the extent of the finding, while growth pattern, borders, and internal characteristics contribute to imaging-based risk assessment. Because no single feature establishes the final classification, clinicians integrate these observations with examination findings and, when indicated, cellular or tissue analysis.
Imaging can characterize a nodule’s appearance, but it does not directly show whether its cells have atypia or whether tissue invasion is present. Cytology examines sampled cells, whereas biopsy permits histopathologic assessment of tissue. These methods add cellular and structural evidence, helping clinicians resolve findings that imaging alone cannot classify with confidence.
The key distinction depends on cellular atypia and invasion identified through cytology or histopathology. Atypia refers to abnormal cellular features, while invasion indicates extension into surrounding tissue. Evaluating these findings moves classification beyond size or appearance and supplies clinically relevant evidence for determining whether a nodule behaves as benign or malignant.
Assessment begins with physical examination and imaging to document the nodule’s size, growth pattern, borders, and internal features. If the findings require cellular or tissue confirmation, clinicians use cytology or biopsy and evaluate atypia, invasion, and other histopathologic findings. The combined evidence then supports risk assessment, classification, and treatment planning.
Management depends on the clinical assessment and the nodule’s effects on the patient. A benign nodule may be monitored when immediate intervention is not required, while symptom-directed treatment can address problems associated with the nodule. This approach supports individualized care and may avoid unnecessary intervention when findings do not indicate malignant behavior.
A malignant classification can lead to treatment planning that includes surgery, systemic therapy, or additional staging. Staging supplies further information for planning the extent and context of care, while the available clinical and histopathologic findings help guide individualized decisions. Accurate classification therefore connects diagnostic assessment with the next management steps.